Clinical Trial Update: A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

Provectus Pharmaceuticals completed a Phase 2 trial evaluating PH-10 for the treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PH-10

Snippet

Sponsor: Provectus Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED